EP Patent

EP2261211A1 — 1,4-dihydropyridine derivatives and their uses

Assigned to Universite Lille 2 Droit et Sante · Expires 2010-12-15 · 15y expired

What this patent protects

The present invention relates to 1,4-dihydropyridine derivatives of the formula (I) and their uses in the treatment and/or prevention of diseases and disorders directly or indirectly associated with the modification (increase or decrease) of the activity of the cannabinoid recept…

USPTO Abstract

The present invention relates to 1,4-dihydropyridine derivatives of the formula (I) and their uses in the treatment and/or prevention of diseases and disorders directly or indirectly associated with the modification (increase or decrease) of the activity of the cannabinoid receptor 2 (CB2).

Drugs covered by this patent

Patent Metadata

Patent number
EP2261211A1
Jurisdiction
EP
Classification
—
Expires
2010-12-15
Drug substance claim
No
Drug product claim
No
Assignee
Universite Lille 2 Droit et Sante
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.